Hospital costs associated with adverse events in people with diabetes in the UK.
Journal article
Keng MJ. et al, (2022), Diabetes Obes Metab
The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model.
Journal article
Emamipour S. et al, (2022), Acta Diabetol
Efficacy of Liposomal Bupivacaine and Bupivacaine Hydrochloride vs Bupivacaine Hydrochloride Alone as a Periarticular Anesthetic for Patients Undergoing Knee Replacement: A Randomized Clinical Trial.
Journal article
Hamilton TW. et al, (2022), JAMA Surg
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses.
Journal article
Freeman D. et al, (2022), Lancet Psychiatry
Health-related quality of life for normal glycaemia, prediabetes and type 2 diabetes mellitus: Cross-sectional analysis of the ADDITION-PRO study.
Journal article
Leal J. et al, (2022), Diabet Med
Cost-effectiveness of home-based stroke rehabilitation across Europe: A modelling study.
Journal article
Candio P. et al, (2022), Health Policy
Clinical and Cost-Effectiveness of Liposomal Bupivacaine and Bupivacaine Hydrochloride vs. Bupivacaine Hydrochloride alone as Peri-Articular Anaesthetic for Replacement of the Knee
Journal article
HAMILTON T. et al, (2022), JAMA Surgery
Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge.
Journal article
Tew M. et al, (2021), Med Decis Making
Decrements in health-related quality of life associated with adverse events in people with diabetes.
Journal article
Keng MJ. et al, (2021), Diabetes Obes Metab
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: a cost-utility analysis based on the EXSCEL trial.
Journal article
Becker F. et al, (2021), Diabetes Res Clin Pract
Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
Journal article
Keng MJ. et al, (2021), Value in Health
Home-based rehabilitation programme compared with traditional physiotherapy for patients at risk of poor outcome after knee arthroplasty: the CORKA randomised controlled trial.
Journal article
Barker KL. et al, (2021), BMJ Open, 11
Appraisal of patient-level health economic models of severe mental illness: systematic review
Journal article
Altunkaya J. et al, (2021), The British Journal of Psychiatry, 1 - 12
A home-based rehabilitation programme compared with traditional physiotherapy for patients at risk of poor outcome after knee arthroplasty: The CORKA randomised controlled trial.
Journal article
BARKER K. et al, (2021), BMJ Open
An Intuitive Risk Communication Tool to Enhance Patient-Provider Partnership in Diabetes Consultation.
Journal article
Rouyard T. et al, (2021), J Diabetes Sci Technol
Cost-Effectiveness of Mechanical Thrombectomy for Treatment of Nonminor Ischemic Stroke Across Europe.
Journal article
Candio P. et al, (2021), Stroke, 52, 664 - 673
Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort
Journal article
Keng MJ. et al, (2021), Value in Health
Prediction of mortality and major cardiovascular complications in type 2 diabetes: External validation of UK Prospective Diabetes Study outcomes model version 2 in two European observational cohorts.
Journal article
Pagano E. et al, (2020), Diabetes Obes Metab
Health-related quality of life in people with predementia Alzheimer's disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review.
Journal article
Landeiro F. et al, (2020), Alzheimers Res Ther, 12
Outpatient physiotherapy versus home-based rehabilitation for patients at risk of poor outcomes after knee arthroplasty: CORKA RCT.
Journal article
Barker KL. et al, (2020), Health Technol Assess, 24, 1 - 116